All of the following produce Osteoblastic secondaries except –
**Core Concept**
Osteoblastic secondaries refer to metastatic bone lesions that stimulate new bone formation, often leading to increased bone density. This phenomenon is typically associated with tumors that produce parathyroid hormone-related protein (PTHrP) or other factors that mimic the effects of parathyroid hormone (PTH).
**Why the Correct Answer is Right**
The correct answer is a type of tumor that is known to produce osteolytic (bone-destroying) secondaries, not osteoblastic lesions. Osteolytic lesions are characterized by the activation of osteoclasts, leading to bone resorption and decreased bone density. In contrast, osteoblastic lesions are associated with increased bone formation and density. Tumors that produce osteolytic secondaries often involve the production of factors such as parathyroid hormone-related protein (PTHrP), prostaglandins, or other cytokines that stimulate osteoclast activity.
**Why Each Wrong Option is Incorrect**
* **Option A:** This tumor is known to produce PTHrP, leading to osteoblastic secondaries. PTHrP stimulates osteoblasts to form new bone, resulting in increased bone density.
* **Option B:** This tumor is also associated with osteoblastic secondaries due to the production of PTHrP, which mimics the effects of PTH and stimulates osteoblast activity.
* **Option D:** This tumor can produce both osteolytic and osteoblastic secondaries, depending on the location and type of metastasis. However, it is not the correct answer because it is not entirely osteolytic.
**Clinical Pearl / High-Yield Fact**
When evaluating a patient with metastatic bone disease, it is essential to consider the type of primary tumor and the characteristics of the bone lesions. Osteolytic lesions are often associated with a worse prognosis and more severe bone pain, whereas osteoblastic lesions may be less symptomatic but can still cause significant morbidity.
**Correct Answer:** D.